Companies in Native AI in Healthcare
There are 2,950 companies in Native AI in Healthcare which include OpenEvidence, Abridge Inc, Innovaccer, Tempus, Recursion Pharmaceuticals. 1,093 companies in Native AI in Healthcare are funded, with 466 having secured Series A funding. Till date, the sector has seen the creation of 17 Unicorns. United States has the most number of companies in Native AI in Healthcare (1,074), followed by China
(206), and then India (179).
2026 has seen the creation of 171 Native AI in Healthcare companies. On average, the last 10 years have seen 216 new companies launched every year. Most number of Native AI in Healthcare startups have been founded by alumni from Stanford University, University of California (Berkeley) and Massachusetts Institute of Technology.
Here is a List of top companies in Native AI in Healthcare
1. OpenEvidence
AI powered medical search platform for healthcare professionals. It aggregates, synthesizes, and visualizes clinically relevant evidence in a format. It aims to provide healthcare professionals with accurate and access to medical information, supporting informed decision making in clinical practice. It provides solutions to enhance the accessibility and usability of peer reviewed medical literature for healthcare professionals.
Key facts about OpenEvidence
- Founded Year: 2021
- Location: Miami (United States)
- Stage: Series D
- Total Funding till date: $735M
- Investors: Google Ventures, Sequoia Capital and 21 Others
- Latest Funding Round: Series D, Jan 21, 2026, $*****
- Tracxn Score: 78/100 What is this?
- Competitors Rank: 1 of 193 Competitors
2. Abridge Inc
Provider of AI-based health record platform. It offers a platform offering solutions for individuals to record health details. The users can communicate with the doctors on the care needs and symptoms. The recorded conversation can be presented to the doctor during the appointment. The app highlights the important points during the conversation. The previous record can be maintained in the app for future reference.
Key facts about Abridge Inc
- Founded Year: 2018
- Location: Pittsburgh (United States)
- Stage: Series E
- Total Funding till date: $778M
- Investors: Wittington Ventures, Spark Capital and 35 Others
- Latest Funding Round: Series E, Jun 12, 2025, $*****
- Tracxn Score: 78/100 What is this?
- Competitors Rank: 1 of 195 Competitors

3. Innovaccer
Developer of healthcare data platforms and artificial intelligence agent software. This technology unifies clinical, operational, and financial information from disparate systems to support decision-making. The platform provides tools for population health management, revenue cycle automation, and quality performance tracking. It enables the deployment of automated assistants to streamline administrative workflows, manage patient outreach, and facilitate care coordination across various healthcare settings. The system integrates non-electronic health record data to improve documentation accuracy and support value-based care initiatives.
Key facts about Innovaccer
- Founded Year: 2014
- Location: San Francisco (United States)
- Stage: Series F
- Total Funding till date: $675M
- Investors: WestBridge Capital, Mubadala and 36 Others
- Latest Funding Round: Series F, Jan 09, 2025, $*****
- Tracxn Score: 78/100 What is this?
- Competitors Rank: 3 of 939 Competitors

4. Tempus
Developer of genomic testing and artificial intelligence tools for medicine. This organization provides molecular profiling, algorithmic diagnostic models, and digital pathology services to assist in clinical decision-making. The technology integrates clinical data with sequencing results to identify therapeutic options and potential clinical trial matches. These tools support oncology, neurology, psychiatry, cardiology, and radiology by analyzing biological data to assist in patient care and drug development. The platform facilitates the identification of biomarkers and provides insights into disease progression and treatment responses.
Key facts about Tempus
- Founded Year: 2015
- Location: Chicago (United States)
- Stage: Public
- Total Funding till date: $1.05B
- Investors: T. Rowe Price, New Enterprise Associates and 11 Others
- Latest Funding Round: Post IPO, Jul 30, 2026, $*****
- Tracxn Score: 77/100 What is this?
- Competitors Rank: 4 of 403 Competitors
AI-enabled drug discovery and development platform for novel therapeutics. It focuses on identifying new targets and designing optimized molecules. The platform utilizes biological and chemical datasets, machine learning models, and a supercomputer to accelerate the discovery of medicines. It aims to improve the speed and efficiency of drug development for conditions with high unmet needs, including cancers and rare diseases. The company also forms strategic partnerships to expand its impact on patients.
Key facts about Recursion Pharmaceuticals
- Founded Year: 2013
- Location: New York (United States)
- Stage: Public
- Total Funding till date: $452M
- Investors: Advantage Capital, Baillie Gifford and 47 Others
- Latest Funding Round: Post IPO, Jul 12, 2023, $*****
- Tracxn Score: 72/100 What is this?
- Competitors Rank: 2 of 276 Competitors
